© 2022 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Phase III

Gilead Prepares to Submit Sovaldi/Ledipasvir Combo to FDA

A single pill of Sovaldi (sofosbuvir) and ledipasvir, with or without ribavirin, cured 96 percent of people with genotype 1 of HCV in...

Gilead’s Hep C Combo Therapy Shows 100% Cure Rate in Small Study

Gilead Sciences? pair of investigatory hepatitis C virus therapies led to a 100 percent cure rate among a small cohort of patients.

Hep C Inhibitor PSI-7977 Goes Interferon-Free in Phase III Studies

Princeton, New Jersey-based Pharmasset is putting its lead experimental hepatitis C nucleotide inhibitor to the test in three late-stage...
Advertisement

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.